Cargando…
Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
Autores principales: | Vakil-Gilani, Kiana, O’Rourke, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260451/ https://www.ncbi.nlm.nih.gov/pubmed/32474884 http://dx.doi.org/10.1007/s10067-020-05184-3 |
Ejemplares similares
-
Impact of COVID-19 on rheumatology practice in the UK—a pan-regional rheumatology survey
por: Nune, Arvind, et al.
Publicado: (2021) -
Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
por: Sandhu, Vaneet K, et al.
Publicado: (2022) -
Rheumatology and psychiatry: allies in times of COVID-19
por: Elera-Fitzcarrald, Claudia, et al.
Publicado: (2021) -
Improving access to care for rheumatology services in Canada
por: Kwok, Timothy S. H., et al.
Publicado: (2023) -
Challenges in delivering rheumatology care during COVID-19 pandemic
por: Nune, A., et al.
Publicado: (2020)